[1]
“Synthesis, characterization, and screening for the antimicrobial activity of 2-(3-(2-cyano-2-(p-tolylamino)vinyl)-1H-indol-1-yl)-N-arylacetamide derivatives”, IJC, vol. 63, no. 7, pp. 673–677, Jul. 2024, doi: 10.56042/ijc.v63i7.7350.